Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Borowitz

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Pediatric Blood & Cancer|March 4, 2015
Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2Elizabeth A Raetz, Mitchell S Cairo, Michael J Borowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanningYvette L Kasamon, Richard L Wahl, Harvey A Ziessman, et al.
Cytometry. Part B, Clinical Cytometry|September 15, 2025
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel-recommendations and safeguards for clinical laboratoriesChristopher J Groves, Michael A Linden, Ahmad Al-Attar, et al.
Academic Pathology|September 6, 2021
Pathology Residency Program Special Expertise Tracks Meet the Needs of an Evolving FieldLaura M Wake, Derek B Allison, Alisha D Ware, et al.
Haematologica|April 21, 2019
Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology GroupElizabeth A Raetz, Mignon L Loh, Meenakshi Devidas, et al.
Plos One|September 30, 2016
Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma Are Donor-DerivedGenevieve M Crane, Mark A Samols, Laura A Morsberger, et al.
Pediatric Blood & Cancer|March 2, 2011
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906W Paul Bowman, Eric L Larsen, Meenakshi Devidas, et al.
Academic Pathology|July 7, 2018
The Evolution of Earned, Transparent, and Quantifiable Faculty Salary Compensation: The Johns Hopkins Pathology ExperienceKathleen H Burns, Michael J Borowitz, Karen C Carroll, et al.
Blood|December 30, 2017
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALLBrent Wood, David Wu, Beryl Crossley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2017
Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupNaomi Winick, Meenakshi Devidas, Si Chen, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Pediatric Blood & Cancer|March 4, 2015
Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2Elizabeth A Raetz, Mitchell S Cairo, Michael J Borowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanningYvette L Kasamon, Richard L Wahl, Harvey A Ziessman, et al.
Cytometry. Part B, Clinical Cytometry|September 15, 2025
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel-recommendations and safeguards for clinical laboratoriesChristopher J Groves, Michael A Linden, Ahmad Al-Attar, et al.
Academic Pathology|September 6, 2021
Pathology Residency Program Special Expertise Tracks Meet the Needs of an Evolving FieldLaura M Wake, Derek B Allison, Alisha D Ware, et al.
Haematologica|April 21, 2019
Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology GroupElizabeth A Raetz, Mignon L Loh, Meenakshi Devidas, et al.
Plos One|September 30, 2016
Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma Are Donor-DerivedGenevieve M Crane, Mark A Samols, Laura A Morsberger, et al.
Pediatric Blood & Cancer|March 2, 2011
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906W Paul Bowman, Eric L Larsen, Meenakshi Devidas, et al.
Academic Pathology|July 7, 2018
The Evolution of Earned, Transparent, and Quantifiable Faculty Salary Compensation: The Johns Hopkins Pathology ExperienceKathleen H Burns, Michael J Borowitz, Karen C Carroll, et al.
Blood|December 30, 2017
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALLBrent Wood, David Wu, Beryl Crossley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2017
Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupNaomi Winick, Meenakshi Devidas, Si Chen, et al.
Pageof 15